Protocol summary

Study aim
This study aimed to evaluate the effect of two doses of magnesium sulphate on cardiovascular changes during general anesthesia in laparoscopic surgeries of women.
Design
Groups and their number were determined by the anesthetist nurse who did not play a role in study.In the days that me was in hospital and was a woman's laparoscopic surgery, she presented a 50-cc syringe to me for injection that contained either 30 mg magnesium sulfate, 50 or without sulfate. after inject, i write the Symptoms of the patient and then back the form to the nurse for write the dose of sulfate magnesium and archives form.
Settings and conduct
The place of the study was Shahid Beheshti Hospital and Alzahra Hospital in Isfahan. Groups and their number were determined by the anesthetist nurse who did not play a role in study.In the days that me was in hospital and was a woman's laparoscopic surgery, she presented a 50-cc syringe to me for injection that contained either 30 mg magnesium sulfate, 50 or without sulfate. after inject, i write the Symptoms of the patient and then back the form to the nurse for write the dose of sulfate magnesium and archives form.
Participants/Inclusion and exclusion criteria
Candidate for laparoscopic surgery for women including ASA patients 1 and 2
Intervention groups
Patients were divided into three groups of placebo (p): 36; the group receiving 30 mg / kg magnesium sulfate (M1) was 35 and the group receiving 50 mg / kg magnesium sulfate (M2) was divided into 35
Main outcome variables
Changes in blood pressure, changes in heart rate

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20190105042236N1
Registration date: 2019-02-10, 1397/11/21
Registration timing: retrospective

Last update: 2019-02-10, 1397/11/21
Update count: 0
Registration date
2019-02-10, 1397/11/21
Registrant information
Name
Mona Mostashfi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 31 3267 9440
Email address
amirmostashfi@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2016-10-22, 1395/08/01
Expected recruitment end date
2017-02-19, 1395/12/01
Actual recruitment start date
2016-10-22, 1395/08/01
Actual recruitment end date
2017-05-20, 1396/02/30
Trial completion date
2017-05-20, 1396/02/30
Scientific title
Effect of prophylactic administration of two doses of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery compared with women in the placebo group attending
Public title
Effect of prophylactic administration of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
Patients ASA 1 Patients ASA 2 Women Laparoscopic Surgery Outer uterus and endometriosis and diagnosis (infertility) Maximum operating time is 150 minutes
Exclusion criteria:
High blood pressure Sensitization to magnesium sulfate Heart block Emergency situation
Age
No age limit
Gender
Female
Phase
2-3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
Sample size
Target sample size: 100
Actual sample size reached: 106
Randomization (investigator's opinion)
Randomized
Randomization description
This study was performed on patients who underwent surgery in Shahid Beheshti and Alzahra Hospitals in Isfahan during the study days as a simple randomized method.So that the syringes of the drug studied by the anesthetist nurse who did not play a role in the data were fill up during the study of the performed surgical operations with a volume of 50 cc(This 50 cc contain 30 cc dose of sulfate or contain 50 cc dose of sulfate or neutral and there was a dose that the injector who was a slave or someone else did not know about this agent)
Blinding (investigator's opinion)
Double blinded
Blinding description
This study was performed on patients who underwent surgery in Shahid Beheshti and Alzahra Hospitals in Isfahan during the study days as a simple randomized method.So that the syringes of the drug studied by the anesthetist nurse who did not play a role in the data were fill up during the study of the performed surgical operations with a volume of 50 cc(This 50 cc contain 30 cc dose of sulfate or contain 50 cc dose of sulfate or neutral and there was a dose that the injector who was a slave or someone else did not know about this agent)
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Isfahan Medical School
Street address
Alzahra Hospital, Sofeh Blvd, Isfahan Province, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174675731
Approval date
2016-04-17, 1395/01/29
Ethics committee reference number
396140

Health conditions studied

1

Description of health condition studied
Effect of prophylactic administration of two doses of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery
ICD-10 code
E61.2
ICD-10 code description
Magnesium deficiency

Primary outcomes

1

Description
Change of systolic blood pressure
Timepoint
before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum.
Method of measurement
Barometer

2

Description
Change of heart rate
Timepoint
before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum.
Method of measurement
Pulse oximeter

Secondary outcomes

1

Description
The amount of chills and vomiting
Timepoint
After the recovery
Method of measurement
Objective observation and question

Intervention groups

1

Description
Intervention group: Magnesium sulfate at a dose of 30 mg / kg
Category
Prevention

2

Description
Intervention group: Magnesium sulfate at a dose of 50 mg / kg
Category
Prevention

3

Description
Control group: Without getting magnesium sulfat
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Beheshti Hospital
Full name of responsible person
Dr. Anahita Hirman Pour
Street address
Shahid Beheshti Hospital, Motahari Ave, Isfahan Province, Esfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3236 7001
Email
Shahidbeheshti@mui.ac.ir

2

Recruitment center
Name of recruitment center
Alzahra Hospital
Full name of responsible person
Dr. Anahita Hirman Pour
Street address
Alzahra Hospital, Sofeh Blvd, Isfahan.
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
alzahra@mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Dr. Hagh Javi
Street address
Alzahra Hospital, Sofeh Blvd, Isfahan Province, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8138
Email
sh_haghjoo@med.mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mona Mostashfi
Position
Assistant Student of Anesthesiology and Special Care
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No.15, Keihan ALye, Bisim Ave, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8157764863
Phone
+98 31 3267 9440
Fax
Email
amirmostashfi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mona Mostashfi
Position
Assistant Student of Anesthesiology and Special Care
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No.15, Keihan ALye, Bisim Ave, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8157764863
Phone
+98 31 3267 9440
Fax
Email
amirmostashfi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Mona Mostashfi
Position
Assistant Student of Anesthesiology and Special Care
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No.15, Keihan ALye, Bisim Ave, Isfahan
City
Isfahan
Province
Isfehan
Postal code
8157764863
Phone
+98 31 3267 9440
Fax
Email
amirmostashfi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All personal information can be provided after the name is deleted
When the data will become available and for how long
Start access after posting the related article after 1398
To whom data/document is available
Researchers working in academia and academia
Under which criteria data/document could be used
To develop this study
From where data/document is obtainable
Email me. m43.mostashfi@gmail.com
What processes are involved for a request to access data/document
Data is provided after examining the individual's request and ensuring proper use and insertion of the data source
Comments
Loading...